Polyclonal B cells acquire LCMV antigens in a GP1-dependent manner
PLOS Pathogens · 2025
DOI: 10.1371/journal.ppat.1013345 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Gabriel Chamberlain und 8 weiteren Autor:innen. Beteiligte Einrichtung: Immunovirology Laboratory, Institut national de la recherche scientifique (INRS), Centre Armand-Frappier Santé Biotechnologie, Laval, Québec, Canada. Hauptthemen laut MEDLINE: B-Lymphocytes, Lymphocytic choriomeningitis virus, Antigen Presentation, Antigens, Viral. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The polyclonal, T-dependent nature of hypergammaglobulinemia during murine infection with LCMV is well defined, however the mechanism by which polyclonal B cells acquire antigens for presentation remains unknown. Here we use LCMV-specific CD4 + transgenic T cells to explore several hypotheses for B cell antigen uptake. We found that antigens produced by cells infected with LCMV in vitro are available to polyclonal B cells and their presentation to CD4+ T cells enabled robust co-activation. The in vitro nature of our model demonstrates that in vivo factors such as cytokine milieu and antigen release by NK/CD8+ are not required. We show that non-replicative UVC-irradiated LCMV enables antigen access to B cells, thus productive infection of B cells is not required for antigen acquisition. B cells loaded with LCMV antigens in vitro can efficiently present these antigens to CD4+ T cells in LCMV-infected mice, thereby validating our model in vivo . Using transmission electron microscopy we identified LCMV-GP bearing particles of various sizes including
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Immunovirology Laboratory, Institut national de la recherche scientifique (INRS), Centre Armand-Frappier Santé Biotechnologie, Laval, Québec, Canada.
- Department of Medicine, Division of Pulmonary Disease and Critical Care Medicine, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, Vermont, United States of America.
ORCID-Profile: Alain Lamarre
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- National Institutes of Health
- Canadian Institutes for Health Research
Zitieren
APA
Chamberlain, G., Lopez, G. L., Bourguignon, L., Laulhé, X., Adda-Bouchard, Y., Charpentier, T., Honce, R., Botten, J. W., & Lamarre, A. (2025). Polyclonal B cells acquire LCMV antigens in a GP1-dependent manner. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013345
Vancouver
Chamberlain G, Lopez GL, Bourguignon L, Laulhé X, Adda-Bouchard Y, Charpentier T, et al. Polyclonal B cells acquire LCMV antigens in a GP1-dependent manner. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1013345
BibTeX
@article{Chamberlain2025,
author = {Chamberlain, Gabriel and Lopez, Guillaume L and Bourguignon, Léa and Laulhé, Xavier and Adda-Bouchard, Yasmine and Charpentier, Tania and Honce, Rebekah and Botten, Jason W and Lamarre, Alain},
title = {Polyclonal B cells acquire LCMV antigens in a GP1-dependent manner},
journal = {PLOS Pathogens},
year = {2025},
doi = {10.1371/journal.ppat.1013345}
}
EUVIMED